RNA, U6atac small nuclear 3, pseudogene (RNU6ATAC3P)

RNU6ATAC3P is a human pseudogene representing a non-coding RNA sequence related to U6atac snRNA, which is part of the minor spliceosomal complex involved in the splicing of pre-mRNA in eukaryotes[1][5]. Unlike functional U6atac snRNA, which helps catalyze specific splicing reactions, pseudogenes such as RNU6ATAC3P do not encode functional snRNA molecules and typically lack biological activity. Pseudogenes can arise via retrotranspositional events and may be integrated into genomic sequence through mechanisms such as L1-mediated retrotransposition[5]. There is no evidence that RNU6ATAC3P encodes an active receptor, enzyme, transporter, transcription factor, or signaling molecule, nor is it known to be involved in any disease, drug interaction, or biomarker application. Most pseudogenes, including those derived from snRNAs like RNU6ATAC3P, are generally considered **non-functional genomic elements** (sometimes mistakenly called “junk DNA”), but recent studies indicate some pseudogene RNAs may participate in subtle gene regulation through mechanisms such as RNA interference or as competing endogenous RNAs[7]. However, there is no evidence for such a role specific to RNU6ATAC3P. Key Points: - RNU6ATAC3P is a canonical pseudogene; it does not function as a receptor or traditional therapeutic target[1][4][5]. - No established role in human disease, pharmacology, or diagnostics. - No interacting drugs or known mechanism of action. - It is appropriately classified as a small nuclear RNA pseudogene, not a receptor, enzyme, or drug target.

Other names

RNU6ATAC3PRNA, U6atac small nuclear 3 pseudogene